Literature DB >> 2526229

Differential induction of cytolytic susceptibility by E1A, myc, and ras oncogenes in immortalized cells.

J L Cook1, D L May, B A Wilson, T A Walker.   

Abstract

The E1A oncogene of adenovirus serotypes 2 and 5 induces susceptibility to the cytolytic effects of natural killer lymphocytes and activated macrophages when expressed in infected and transformed mammalian cells (cytolysis-susceptible phenotype). E1A and the oncogenes v-myc, long-terminal-repeat-promoted c-myc, and activated c-ras share the ability to immortalize transfected low-passage rodent cells. The cytolytic phenotypes of well-characterized rodent cell lines immortalized by these three oncogenes were defined. In contrast to target cells expressing the intact E1A gene, myc- and ras-expressing, immortalized primary transfectants were resistant to lysis by both types of killer cell populations. The same patterns of susceptibility (E1A) and resistance (myc and ras) to cytolysis were observed in oncogene-transfected continuous rat (REF52) and mouse (NIH 3T3) cell lines, indicating that differences in the cytolytic phenotypes associated with expression of these oncogenes are not due to cell selection during immortalization. The results suggest that the E1A oncogene may possess a functional domain that is different from those of other oncogenes, such as myc and ras, and that the activity linked to this postulated domain is dissociable from the process of immortalization.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2526229      PMCID: PMC250916     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  The natural history of cancer.

Authors:  L FOULDS
Journal:  J Chronic Dis       Date:  1958-07

Review 2.  Morphological and functional characterization of isolated effector cells responsible for human natural killer activity to fetal fibroblasts and to cultured cell line targets.

Authors:  E Saksela; T Timonen; A Ranki; P Häyry
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

3.  Establishment of a cell line from an inbred mouse strain for viral transformation studies: simian virus 40 transformation and tumor production.

Authors:  K K Takemoto; R C Ting; H L Ozer; P Fabisch
Journal:  J Natl Cancer Inst       Date:  1968-12       Impact factor: 13.506

4.  An adenovirus mutant defective in splicing RNA from early region 1A.

Authors:  D Solnick
Journal:  Nature       Date:  1981-06-11       Impact factor: 49.962

5.  Host response to adenovirus 2-transformed hamster embryo cells.

Authors:  J L Cook; A M Lewis
Journal:  Cancer Res       Date:  1979-05       Impact factor: 12.701

6.  Transformation by adenovirus early region 2A temperature-sensitive mutants and their revertants.

Authors:  J Logan; J C Nicolas; W C Topp; M Girard; T Shenk; A J Levine
Journal:  Virology       Date:  1981-12       Impact factor: 3.616

7.  DNA virus-transformed hamster cell--host effector cell interactions: level of resistance to cytolysis correlated with tumorigenicity.

Authors:  J L Cook; J B Hibbs; A M Lewis
Journal:  Int J Cancer       Date:  1982-12-15       Impact factor: 7.396

8.  Resistance of simian virus 40-transformed hamster cells to the cytolytic effect of activated macrophages: a possible factor in species-specific viral oncogenicity.

Authors:  J L Cook; J B Hibbs; A M Lewis
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

9.  Interactions of adenovirus type 2 with rat embryo cells. Permissiveness, transformation and in vitro characteristics of adenovirus transformed rat embryo cells.

Authors:  P H Gallimore
Journal:  J Gen Virol       Date:  1974-11       Impact factor: 3.891

10.  Tumour-necrosis factor from the rabbit. II. Production by monocytes.

Authors:  N Matthews
Journal:  Br J Cancer       Date:  1978-08       Impact factor: 7.640

View more
  5 in total

1.  Expression of an E1A/E7 chimeric protein sensitizes tumor cells to killing by activated macrophages but not NK cells.

Authors:  Tanya A Miura; Han Li; Kristin Morris; Sharon Ryan; Kristine Hembre; James L Cook; John M Routes
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

2.  E1A oncogene induction of cytolytic susceptibility eliminates sarcoma cell tumorigenicity.

Authors:  T A Walker; B A Wilson; A M Lewis; J L Cook
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

3.  Induction of sensitivity to the cytotoxic action of tumor necrosis factor alpha by adenovirus E1A is independent of transformation and transcriptional activation.

Authors:  R S Ames; B Holskin; M Mitcho; D Shalloway; M J Chen
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

4.  Cooperation between bovine leukaemia virus transactivator protein and Ha-ras oncogene product in cellular transformation.

Authors:  L Willems; H Heremans; G Chen; D Portetelle; A Billiau; A Burny; R Kettmann
Journal:  EMBO J       Date:  1990-05       Impact factor: 11.598

5.  The circadian mutation PER2(S662G) is linked to cell cycle progression and tumorigenesis.

Authors:  X Gu; L Xing; G Shi; Z Liu; X Wang; Z Qu; X Wu; Z Dong; X Gao; G Liu; L Yang; Y Xu
Journal:  Cell Death Differ       Date:  2011-08-05       Impact factor: 15.828

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.